drugset / Trial / NCT02335294

A Study of TRV130 for the Treatment of Pain After Abdominoplasty

NCT02335294

Phase 2 Completed 200 enrolled Trevena Inc. Lotus Clinical Research, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain following abdominoplasty.

Timeline

Start
2014-12
Primary completion
2015-07
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified
Subject Oliceridine Other / unclassified Intravenous

Indications

No indication recorded.